Price movement over the last 24 hours
AdaptHealth Corp vs Elastic NV — how do they compare? AdaptHealth Corp trades at $10.1 (market cap $1.38B), while Elastic NV trades at $59.85 (market cap $6.18B). The key difference: Elastic NV is far larger — about 4.5× AdaptHealth Corp's market cap. Which is the better fit depends on your goals.
| AHCO | ESTC | |
|---|---|---|
Market Cap | $1.38B | $6.18B |
Sector | Health | Technology |
52-Week High | $13.38 | $94.47 |
52-Week Low | $8.68 | $43.30 |
Enterprise Value | $3.33B | $5.40B |
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
Elastic (ESTC) trades at $58.54, up 0.86% with neutral technical signals. The company shows strong profitability metrics including 76% gross margins and 21% net income margin projected for 2026, though 2025 results showed a net loss. Recent earnings beats and positive analyst sentiment (67% buy ratings) support the stock, with a $72.80 consensus price target representing 24% upside potential.
ESTC presents a growth opportunity with improving financials and market leadership in search AI, though risks include ongoing legal investigations and competitive pressures. The stock's current valuation appears reasonable relative to growth prospects, with technical indicators suggesting consolidation near key support at $57.
Trailing returns across standard periods
Latest headlines on both assets
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →Elastic NV provides a leading search AI platform built on Elasticsearch. Its software helps organizations find, observe, and protect data through search-powered analytics for various cloud-based applications.
Read more on ESTC →